A client with a dinoprostone vaginal insert develops uterine… | MyMerci
Adverse Effects/Contraindications/Interactions PPT
Question

A client with a dinoprostone vaginal insert develops uterine tachysystole with recurrent late fetal-heart-rate decelerations. Which action should the nurse take first?

Explanation
The removable dinoprostone insert should be removed for tachysystole, fetal distress, or before oxytocin. Immediate removal ends further drug delivery while the fetal response is addressed.
Next question on this topicA nurse is reviewing the morning lab results for an adult client receiving warfarin for at…

In-depth explanation

Quick answer
For CERVIDIL, tachysystole plus late decelerations means remove the insert now.

Why this is correct
Leaving the controlled-release insert in place continues prostaglandin exposure during fetal compromise.

Easy analogy or mental picture
Build a medication-safety chain: identify the new cue, connect it to the drug mechanism or labeled limitation, stop preventable exposure, stabilize the client, and verify a measurable response.

Memory hook
Drug, urgent cue, protective action, and reassessment endpoint.

NCLEX decision rule
Choose the action that prevents the most immediate medication-related harm while preserving indicated treatment and required monitoring.

Why the other choices are wrong
Options that continue a suspect exposure, normalize a labeled danger cue, substitute an unauthorized dose, or delay escalation leave the client at risk.
References
1DailyMed: CERVIDIL (dinoprostone insert)Removal for tachysystole or fetal distress and before oxytocin

Clinical scenario

Medication-safety review
Verify indication, current assessment, dose and route, organ function, interactions, urgent toxicity cues, authorized action, and measurable follow-up.
Browse all questions No login required

Master the NCLEX-RN with MyMerci

Thousands of NCLEX-style questions with detailed rationale — in your language. Track your progress and study smarter.

Start for free
Read in another language: English한국어日本語繁體中文Tiếng Việt

For study reference only. Always follow current clinical guidelines and your institution’s protocols.